Envista Holdings Corp (NVST)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $3.93B
Last updated: Nov 17, 2026 at 11:06 AM ET
Envista Holdings Corp (NVST) Financials: Revenue, Profit and Cash Flow
Envista Holdings reported revenue of $2.72B for the fiscal year ended Dec 31, 2025, up 8.3% from the year before. That year, net income was $47.00M with a net margin of 1.7%, operating cash flow was $275.70M and free cash flow was $230.40M. The quarter ended Sep 30, 2026 had revenue of $691.50M and net income of $508.30M.
Revenue and Margins
The operating margin was 7.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $2.79B, a compound annual decline of 0.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.72B | +8.3% | 54.7% | 7.9% | 1.7% |
| Dec 2024 | $2.51B | -2.2% | 54.7% | -41.4% | -44.6% |
| Dec 2023 | $2.57B | -0.1% | 56.1% | 1.2% | -3.9% |
| Dec 2022 | $2.57B | +2.4% | 57.4% | 12.4% | 9.5% |
| Dec 2021 | $2.51B | +30.1% | 56.9% | 12.2% | 13.6% |
| Dec 2020 | $1.93B | -15.6% | 54.7% | 2.3% | 1.7% |
| Dec 2019 | $2.28B | -19.7% | 59.1% | 10.3% | 9.5% |
| Dec 2018 | $2.84B | +1.2% | 56.3% | 10.5% | 8.1% |
| Dec 2017 | $2.81B | +0.9% | 57.9% | 13.8% | 10.7% |
| Dec 2016 | $2.79B | N/A | 57.9% | 14.5% | 9.8% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.72B | $2.51B | $2.57B | $2.57B | $2.51B | $1.93B | $2.28B | $2.84B | $2.81B | $2.79B |
| Cost of revenue | $1.23B | $1.14B | $1.13B | $1.09B | $1.08B | $874.30M | $935.60M | $1.24B | $1.18B | $1.17B |
| Gross profit | $1.49B | $1.37B | $1.44B | $1.47B | $1.43B | $1.05B | $1.35B | $1.60B | $1.63B | $1.61B |
| Research and development | $114.00M | $99.10M | $93.80M | $100.10M | $100.50M | $86.70M | $133.10M | $172.00M | $172.40M | $142.80M |
| Operating income | $216.10M | -$1.04B | $31.50M | $319.20M | $306.20M | $43.50M | $235.70M | $298.40M | $386.60M | $402.80M |
| Net income | $47.00M | -$1.12B | -$100.20M | $243.10M | $340.50M | $33.30M | $217.60M | $230.70M | $301.10M | $272.00M |
| EBITDA | $368.70M | -$910.30M | $148.70M | $488.50M | $483.80M | $219.00M | $405.30M | $431.10M | $543.90M | $563.30M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $691.50M | $730.50M | $705.50M | $750.60M | $669.90M | $682.10M | $616.90M | $652.90M | $601.00M | $633.10M | $623.60M | $645.60M |
| Gross profit | $400.60M | $407.00M | $390.10M | $410.60M | $370.20M | $369.90M | $336.00M | $372.50M | $317.30M | $326.60M | $356.30M | $335.90M |
| Operating income | $515.20M | $80.30M | $62.50M | $73.30M | $57.50M | $46.30M | $39.00M | $46.10M | $20.90M | -$1.15B | $48.10M | -$202.80M |
| Net income | $508.30M | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M | $18.00M | $1.20M | $8.20M | -$1.15B | $23.60M | -$217.40M |
Balance Sheet
As of Dec 2025, total debt of $1.49B exceeded cash and equivalents by $275.60M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.68B | $5.35B | $6.61B | $6.59B | $6.57B | $6.88B | $6.16B | $5.84B | $5.99B | N/A |
| Current assets | $2.03B | $1.79B | $1.74B | $1.42B | $1.84B | $1.59B | $1.00B | $786.80M | $794.50M | N/A |
| Cash and equivalents | $1.21B | $1.07B | $940.00M | $606.90M | $1.07B | $888.90M | $211.20M | $0 | $0 | N/A |
| Total liabilities | $2.57B | $2.42B | $2.43B | $2.38B | $2.52B | $3.15B | $2.62B | $1.02B | $998.20M | N/A |
| Short-term debt | $39.00M | $116.00M | $115.30M | $510.00M | $432.40M | $886.80M | $3.90M | $0 | $216.70M | N/A |
| Long-term debt | $1.45B | $1.28B | $1.40B | $870.70M | $883.40M | $907.70M | $1.32B | $0 | $0 | N/A |
| Shareholder equity | $3.11B | $2.93B | $4.17B | $4.21B | $4.06B | $3.72B | $3.54B | $4.82B | $4.99B | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.61B | $5.60B | $5.58B | $5.68B | $5.64B | $5.66B | $5.47B | $5.35B | $5.51B | $5.44B | $6.56B | $6.61B |
| Total liabilities | $2.52B | $2.52B | $2.50B | $2.57B | $2.55B | $2.53B | $2.43B | $2.42B | $2.44B | $2.46B | $2.42B | $2.43B |
| Cash and equivalents | $1.16B | $1.13B | $1.08B | $1.21B | $1.13B | $1.11B | $1.08B | $1.07B | $991.30M | $1.04B | $948.50M | $940.00M |
| Shareholder equity | $3.09B | $3.08B | $3.08B | $3.11B | $3.09B | $3.14B | $3.04B | $2.93B | $3.07B | $2.98B | $4.14B | $4.17B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 83.6% of operating cash flow. Share repurchases came to 72.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $275.70M | $336.50M | $275.70M | $182.70M | $361.60M | $283.90M | $397.50M | $400.10M | $359.10M | $417.00M |
| Capital expenditures | $45.30M | $33.80M | $58.20M | $75.70M | $54.70M | $47.70M | $77.80M | $72.20M | $48.90M | $49.10M |
| Free cash flow | $230.40M | $302.70M | $217.50M | $107.00M | $306.90M | $236.20M | $319.70M | $327.90M | $310.20M | $367.90M |
| Dividends paid | N/A | N/A | N/A | $12.70M | $12.30M | $8.80M | $116.50M | $324.60M | $0 | $0 |
| Share repurchases | $166.60M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$51.10M | -$54.60M | -$62.40M | -$657.30M | $262.70M | -$69.10M | -$78.40M | -$75.50M | -$54.90M | -$59.40M |
| Financing cash flow | -$170.90M | -$103.70M | $118.90M | $12.50M | -$465.60M | $492.50M | -$107.70M | -$324.60M | -$304.20M | -$357.60M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $77.90M | $119.20M | -$3.30M | $108.00M | $78.70M | $88.70M | $300.00K | $132.40M | $70.70M | $93.10M | $40.30M | $102.00M |
| Capital expenditures | $16.10M | $14.90M | $12.50M | $16.30M | $10.80M | $12.30M | $5.90M | $8.60M | $7.40M | $6.80M | $11.00M | $8.20M |
| Free cash flow | $61.80M | $104.30M | -$15.80M | $91.70M | $67.90M | $76.40M | -$5.60M | $123.80M | $63.30M | $86.30M | $29.30M | $93.80M |
Frequently Asked Questions About NVST
What is Envista Holdings' annual revenue?
Envista Holdings reported revenue of $2.72B for the fiscal year ended Dec 31, 2025.
How fast is Envista Holdings' revenue growing?
Revenue was up 8.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 1.9%.
Is Envista Holdings profitable?
Yes. Envista Holdings reported net income of $47.00M for the fiscal year ended Dec 31, 2025, with a net margin of 1.7%.
How much free cash flow does NVST generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $275.70M minus capital expenditures of $45.30M produced free cash flow of $230.40M.
How much debt does Envista Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.45B, short-term debt of $39.00M and cash and equivalents of $1.21B.
NVST pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors